| 000 -LEADER |
|---|
| fixed length control field |
00703nam a22002057a 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20130310192907.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
110713t xxu||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9241208821pbk |
| 040 ## - CATALOGING SOURCE |
|---|
| Transcribing agency |
UG |
| 050 ## - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RA 8T4W67 No. 882 |
| 110 ## - MAIN ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
WHO Expert Committee on the use of Essential Drugs(8th : 1997: Geneva). |
| 9 (RLIN) |
53633 |
| 245 ## - TITLE STATEMENT |
|---|
| Title |
The use of essentials drugs: |
| Remainder of title |
Report of the WHO expert committee( Includeing the revised model list of essential drugs).- |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
Geneva.: |
| Name of publisher, distributor, etc |
World Health Organization, |
| Date of publication, distribution, etc |
1998. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
vi, 77p.- |
| 490 ## - SERIES STATEMENT |
|---|
| Series statement |
(WHO technical report series; 882). |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Drugs |
| Form subdivision |
Standards. |
| 9 (RLIN) |
53634 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
|